Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Controversies and priorities in amyotrophic lateral sclerosis
Martin R. Turner, Orla Hardiman, Michael Benatar, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 3, pp. 310-322
Open Access | Times Cited: 511

Showing 1-25 of 511 citing articles:

State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton, Adriano Chiò, Bryan J. Traynor
Nature Neuroscience (2013) Vol. 17, Iss. 1, pp. 17-23
Open Access | Times Cited: 1424
Amyotrophic lateral sclerosis
Michael A. van Es, Orla Hardiman, Adriano Chiò, et al.
The Lancet (2017) Vol. 390, Iss. 10107, pp. 2084-2098
Closed Access | Times Cited: 1107
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Nature (2019) Vol. 572, Iss. 7770, pp. 474-480
Open Access | Times Cited: 567
Large-scale genomics unveils the genetic architecture of psychiatric disorders
Jacob Gratten, Naomi R. Wray, Matthew C. Keller, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 6, pp. 782-790
Open Access | Times Cited: 355
Amyotrophic lateral sclerosis: moving towards a new classification system
Ammar Al‐Chalabi, Orla Hardiman, Matthew C. Kiernan, et al.
The Lancet Neurology (2016) Vol. 15, Iss. 11, pp. 1182-1194
Open Access | Times Cited: 342
Genetics of amyotrophic lateral sclerosis: an update
Sheng Chen, Pavani Sayana, Xiaojie Zhang, et al.
Molecular Neurodegeneration (2013) Vol. 8, Iss. 1
Open Access | Times Cited: 310
Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto, Benjamin Rix Brooks, Vincenzo Silani
The Lancet Neurology (2014) Vol. 13, Iss. 11, pp. 1127-1138
Closed Access | Times Cited: 260
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes
Adriano Chiò, Marco Pagani, Federica Agosta, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 12, pp. 1228-1240
Closed Access | Times Cited: 234
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 231
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response
Peng Wang, Jianwen Deng, Jie Dong, et al.
PLoS Genetics (2019) Vol. 15, Iss. 5, pp. e1007947-e1007947
Open Access | Times Cited: 227
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 11, pp. 1059-1067
Closed Access | Times Cited: 224
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
Patrick Weydt, Patrick Oeckl, André Huss, et al.
Annals of Neurology (2015) Vol. 79, Iss. 1, pp. 152-158
Closed Access | Times Cited: 208
TMPyP4 Porphyrin Distorts RNA G-quadruplex Structures of the Disease-associated r(GGGGCC)n Repeat of the C9orf72 Gene and Blocks Interaction of RNA-binding Proteins
Bita Zamiri, Kaalak Reddy, Robert B. Macgregor, et al.
Journal of Biological Chemistry (2013) Vol. 289, Iss. 8, pp. 4653-4659
Open Access | Times Cited: 207
Autophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases
Alvin Djajadikerta, Swati Keshri, Mariana Pavel, et al.
Journal of Molecular Biology (2019) Vol. 432, Iss. 8, pp. 2799-2821
Open Access | Times Cited: 201
Pathophysiological and diagnostic implications of cortical dysfunction in ALS
Nimeshan Geevasinga, Parvathi Menon, P. Hande Özdi̇nler, et al.
Nature Reviews Neurology (2016) Vol. 12, Iss. 11, pp. 651-661
Closed Access | Times Cited: 191
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Dora Brites, Ana Rita Vaz
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 190
Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis
Mingdong Wang, Julian Little, James Gomes, et al.
NeuroToxicology (2016) Vol. 61, pp. 101-130
Closed Access | Times Cited: 189
Calcium Signaling Regulates Autophagy and Apoptosis
Pramod Sukumaran, Viviane Nascimento Da Conceicao, Yuyang Sun, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2125-2125
Open Access | Times Cited: 166
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 115
Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut–Liver–Brain Axes?
Huafeng Jian, Yating Liu, Xiaoming Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3900-3900
Open Access | Times Cited: 88
Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration
Frederick J. Arnold, Alexandra F. Putka, Urmimala Raychaudhuri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5587-5587
Open Access | Times Cited: 18
MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis
Janne M. Toivonen, Raquel Manzano, Sara Oliván, et al.
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e89065-e89065
Open Access | Times Cited: 179
PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage
Stuart L. Rulten, Amy Rotheray, Ryan L. Green, et al.
Nucleic Acids Research (2013) Vol. 42, Iss. 1, pp. 307-314
Open Access | Times Cited: 176
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans
Martine Therrien, Guy A. Rouleau, Patrick A. Dion, et al.
PLoS ONE (2013) Vol. 8, Iss. 12, pp. e83450-e83450
Open Access | Times Cited: 175
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
Ricarda Menke, Sonja Körner, Nicola Filippini, et al.
Brain (2014) Vol. 137, Iss. 9, pp. 2546-2555
Open Access | Times Cited: 169
Page 1 - Next Page

Scroll to top